$BIIB News Speculators turn the heat up to ‘soft

New Post Public Reply Private Reply Replies (0) Message Board

Jan 22, 2014 at 3:27 PM

$BIIB News

Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:22 p.m. Jan. 14, 2014 - Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies 9:38 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:28 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:32 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:18 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:55 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Ben Eisen
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro
The Four Horsemen send a message 12:46 p.m. Nov. 13, 2013 - The Trading Deck
Biogen shares hit new high as Tecfidera sales crush estimates 10:50 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Biogen Idec profit up 22% on Tecfidera sales boost 8:09 a.m. Oct. 28, 2013 - MarketWatch.com
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside 8:54 a.m. Today - 247WallSt.com
Cramer's Lightning Round - Stay Long Kinder Morgan Partners (1/21/14) 6:36 a.m. Today - Seeking Alpha
Biogen Idec Now #53 Largest Company, Surpassing Occidental Petroleum 4:41 p.m. Jan. 21, 2014 - TheStreet.com
Biogen Idec (BIIB) Showing Signs Of Being A Momo Momentum Stock 9:49 a.m. Jan. 21, 2014 - TheStreet.com
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry 7:19 a.m. Jan. 21, 2014 - Seeking Alpha
Can JNJ Keep the Earnings Streak Alive? - Analyst Blog 3:12 p.m. Jan. 20, 2014 - Zacks.com
Biogen Idec: 4 Different Insiders Have Sold Shares This Year 1:14 a.m. Jan. 20, 2014 - Seeking Alpha
GCVRZ: Betting On The Sales Of Lemtrada In A Moving MS Drug Market 2:05 p.m. Jan. 19, 2014 - Seeking Alpha
Gilead Is Not Done; There Is Potentially 50% More Upside This Year 5:32 p.m. Jan. 17, 2014 - Seeking Alpha
Biogen Idec Inc (BIIB): Today's Featured Drugs Winner 5:00 p.m. Jan. 17, 2014 - TheStreet.com
J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech 3:30 p.m. Jan. 17, 2014 - TheStreet.com
Generic Unit at Perrigo Looks Promising - Analyst Blog 11:30 a.m. Jan. 17, 2014 - Zacks.com
Insider Trading Alert - BIIB, MDAS, SPLK, IBKR And AMTD Traded By Insiders 10:30 a.m. Jan. 17, 2014 - TheStreet.com
Interesting BIIB Put And Call Options For February 14th 11:20 a.m. Jan. 16, 2014 - TheStreet.com
Biogen, Celgene Lead 5 Top Large-Cap Drugmakers 7:05 a.m. Jan. 15, 2014 - Investors Business Daily
9 Biotechnology Stocks to Buy Now 6:30 a.m. Jan. 15, 2014 - InvestorPlace.com
ACOR Preliminary Q4 Revs Look Good - Analyst Blog 11:40 a.m. Jan. 14, 2014 - Zacks.com
Merck Turnaround Is Working Out Well 11:15 a.m. Jan. 14, 2014 - Barrons.com
Facebook, Other Big Cap 20 Leaders Fall In Low Volume 5:49 p.m. Jan. 13, 2014 - Investors Business Daily
Biotech Stocks Back On Top, Led By Biogen, Alexion 5:07 p.m. Jan. 13, 2014 - Investors Business Daily

RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market 5:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 4:01 p.m. Jan. 15, 2014 - BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase 5:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis 4:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference 9:49 a.m. Jan. 14, 2014 - BusinessWire - BZX
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer 9:10 a.m. Jan. 13, 2014 - PR Newswire - PRF
RBCC Partner n3D Commercializes New 3D Bioprinting Technology 5:53 a.m. Jan. 13, 2014 - BusinessWire - BZX
Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies 7:10 a.m. Jan. 9, 2014 - PR Newswire
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies 7:00 a.m. Jan. 9, 2014 - PR Newswire
Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs 6:59 a.m. Jan. 9, 2014 - GlobeNewswire
Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference 5:29 p.m. Jan. 7, 2014 - BusinessWire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference 4:00 p.m. Jan. 2, 2014 - BusinessWire
Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma 8:00 a.m. Dec. 31, 2013 - PR Newswire
Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna 8:00 a.m. Dec. 23, 2013 - PR Newswire
WCG Hires Adam Cohen, Digital Thought Leader, to Strengthen Technology Practice 8:00 a.m. Dec. 17, 2013 - BusinessWire
Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF Biosimilar Product Candidates in Europe 2:00 a.m. Dec. 17, 2013 - BusinessWire
Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America 8:00 a.m. Dec. 13, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

AI-Driven Lumi Transforms Car Dealership Interactions

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Succession Planning in Turmoil: Only 42% Ready

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....